Systemic Consolidation Therapy After Chemoradiation Therapy Following Operation for High Risk Early Stage Cervical Cancer

Mise à jour : Il y a 4 ans
Référence : NCT00592059

Femme Homme

Extrait

The purpose of this study is to determine the therapeutic efficacy and complications of systemic consolidation therapy with paclitaxel plus carboplatin following radical hysterectomy and adjuvant chemoradiation for high risk early stage cervical cancer.


Critère d'inclusion

  • cervical cancer

Liens